HIGHLIGHTS
- who: Evelien Schurgers from the Apitope International NV, Diepenbeek, Belgium, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom have published the research: Induction of Tolerance to Therapeutic Proteins With Antigen-Processing Independent T Cell Epitopes: Controlling Immune Responses to Biologics, in the Journal: (JOURNAL)
- what: Based on the analysis of the mechanism of action of model apitope peptides, the authors have designed an ‘in patient' dose escalation protocol that optimises the generation of Treg cells . The approach has been to identify pan-DR binding epitopes expected to function in a wide range . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.